0001144204-10-059332.txt : 20110708 0001144204-10-059332.hdr.sgml : 20110708 20101112075055 ACCESSION NUMBER: 0001144204-10-059332 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20101112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SignPath Pharma, Inc. CENTRAL INDEX KEY: 0001455694 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205079533 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1375 CALIFORNIA ROAD CITY: QUAKERTOWN STATE: PA ZIP: 18951 BUSINESS PHONE: 267-772-0107 MAIL ADDRESS: STREET 1: 1375 CALIFORNIA ROAD CITY: QUAKERTOWN STATE: PA ZIP: 18951 CORRESP 1 filename1.htm Unassociated Document
SIGNPATH PHARMA INC.
1375 California Road
Quakerton, PA 18951
 
  November 11, 2010
 
VIA EDGAR CORRESPONDENCE

Mr. Jim B. Rosenberg
Senior Assistant Chief Accountant
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549

 
Re:
SignPath Pharma Inc.
 
Form 10-Q for the Quarter Ended June 30, 2010
 
Filed August 23, 2010
File No. 333-158474                                                 

Gentlemen:

On behalf of SignPath Pharma Inc., the undersigned hereby acknowledges that:

 
§
the Company is responsible for the adequacy and accuracy of the disclosure in the filings;
 
§
staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filings; and
 
§
the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 
Very truly yours,
  
       
 
SignPath Pharma Inc.
  
       
       
 
By:
/s/ Lawrence Helson
  
   
Dr. Lawrence Helson, CEO